Medicare Enrolled
Dr. Steve Mermelstein, MD
Pulmonary Disease · Lynbrook, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mermelstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mermelstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mermelstein
Dr. Steve Mermelstein is a pulmonary disease specialist in Lynbrook, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mermelstein performed 2,523 Medicare services across 1,892 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mermelstein received a total of $10,772 from 32 pharmaceutical and/or device companies across 668 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mermelstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in NY
$10,772 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,523
Medicare services
Top 17% in NY for pulmonary disease
1,892
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
750 | $111 | $272 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
272 | $25 | $132 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
217 | $79 | $187 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
214 | $2 | $11 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
203 | $53 | $187 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
171 | $40 | $149 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
146 | $32 | $208 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
104 | $18 | $73 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $148 | $409 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
58 | $36 | $156 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
36 | $30 | $116 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
36 | $78 | $185 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
32 | $17 | $37 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $159 | $360 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
30 | $31 | $116 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
28 | $15 | $102 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
19 | $48 | $113 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
18 | $35 | $50 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
17 | $33 | $104 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
15 | $72 | $118 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
14 | $43 | $84 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
14 | $133 | $263 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,772
Total received (2018-2024)
Avg $1,539/year across 7 years
Top 18% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
668
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,691 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$81 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$281
2023
$193
2022
$2,095
2021
$2,191
2020
$1,636
2019
$2,380
2018
$1,996
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,740
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,016
AstraZeneca Pharmaceuticals LP
$1,334
Grifols USA, LLC
$585
Philips Electronics North America Corporation
$522
Regeneron Healthcare Solutions, Inc.
$497
Genentech USA, Inc.
$459
Mylan Specialty L.P.
$458
Electromed, Inc.
$254
Advanced Respiratory, Inc
$234
GENZYME CORPORATION
$224
Mallinckrodt Hospital Products Inc.
$198
Actelion Pharmaceuticals US, Inc.
$194
Takeda Pharmaceuticals U.S.A., Inc.
$169
Amgen Inc.
$121
Sunovion Pharmaceuticals Inc.
$102
Circassia Pharmaceuticals Inc
$70
Olympus America Inc.
$61
Teva Pharmaceuticals USA, Inc.
$60
United Therapeutics Corporation
$59
SANOFI-AVENTIS U.S. LLC
$57
Gilead Sciences, Inc.
$52
Baxter Healthcare
$49
ADVANCED RESPIRATORY, INC
$46
Shire North American Group Inc
$45
HARMONY BIOSCIENCES LLC
$38
Paratek Pharmaceuticals, Inc.
$35
CSL Behring
$24
Merck Sharp & Dohme LLC
$21
Merck Sharp & Dohme Corporation
$19
Avanir Pharmaceuticals, Inc.
$16
Resmed Corp
$15
Top 3 companies account for 56.5% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) inCourage · ACTHAR · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Astral · BREO · BREZTRI · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DreamStat Cpap Auto · DreamWear Pillows · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 205 Acute Care · Hillrom - VisiVest Airway Clearance System · LONHALA MAGNAIR · NUCALA · NUEDEXTA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Olympus Respiratory Accessories · PNEUMOVAX 23 · PRADAXA · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Sleep Other · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UPTRAVI · Utibron · VT Und · Wakix · Wellcentive Undiv · Xolair · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
539
Per 100K population
38.8
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mermelstein is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with low-engagement industry engagement in the top 18% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mermelstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mermelstein performed 750 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mermelstein receive payments from pharmaceutical companies?
Yes. Dr. Mermelstein received a total of $10,772 from 32 companies across 668 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mermelstein's costs compare to other pulmonary diseases in Lynbrook?
Dr. Mermelstein's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mermelstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Lynbrook
Browse pulmonary diseases in Lynbrook ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology